Sep 2026
A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).
Y. Katsura, Shogo Kobayashi, Yutaka Takeda et al.
· Surgery today (Print) · 0 citations